Literature DB >> 7123180

Diagnostic criteria of rheumatoid arthritis in children. Proposed criteria for controlled clinical studies.

T K Kvien, H M Høyeraal, E Kåss.   

Abstract

Several different sets of diagnostic criteria of rheumatoid arthritis in children are in practical use. The criteria most widely applied are discussed here, especially with regard to clinical studies. Reasons are presented for the selection of criteria used in the present controlled clinical studies on rheumatic children in Oslo. Three modifications were made in the North-American criteria: 1) disease onset before 16 years of age; 2) persistent arthritis for more than 3 months; 3) biopsy is preferable in monarticular cases, except in patients with chronic iridocyclitis.

Entities:  

Mesh:

Year:  1982        PMID: 7123180     DOI: 10.3109/03009748209098189

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  5 in total

1.  Juvenile rheumatoid arthritis--Madras experience.

Authors:  A N Chandrasekaran; C P Rajendran; R Madhavan
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

Review 2.  Immunological features of diffuse connective tissue diseases.

Authors:  G R Burgio; A Martini
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

3.  Oral gold (auranofin) in juvenile rheumatoid arthritis: a 48-week phase II study.

Authors:  T K Kvien; H M Høyeraal; B Sandstad; E Kåss
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

4.  Incidence and prevalence of juvenile chronic arthritis: a population survey.

Authors:  B Andersson Gäre; A Fasth; J Andersson; G Berglund; H Ekström; M Eriksson; L Hammarén; L Holmquist; E Ronge; A Thilen
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

5.  Lymphokines and soluble interleukin-2 receptors in juvenile chronic arthritis. Clinical and laboratory correlations.

Authors:  K Müller; F K Pedersen; A Wiik; K Bendtzen
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.